Premium
Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update
Author(s) -
Patel Priya,
Robinson Paula D.,
Devine Katie A.,
Positano Karyn,
Cohen Marie,
Gibson Paul,
Holdsworth Mark,
Phillips Robert,
Spinelli Daniela,
Thackray Jennifer,
Wetering Marianne,
Woods Deborah,
Cabral Sandra,
Sung Lillian,
Dupuis L. Lee
Publication year - 2021
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.28947
Subject(s) - medicine , chemotherapy induced nausea and vomiting , nausea , guideline , intensive care medicine , vomiting , psychological intervention , oncology , antiemetic , psychiatry , pathology
This 2021 clinical practice guideline update provides recommendations for preventing anticipatory chemotherapy‐induced nausea and vomiting (CINV) in pediatric patients. Recommendations are based on systematic reviews that identified (1) if a history of acute or delayed CINV is a risk factor for anticipatory CINV, and (2) interventions for anticipatory CINV prevention and treatment. A strong recommendation to optimize acute and delayed CINV control in order to prevent anticipatory CINV is made. Conditional recommendations are made for hypnosis, systematic desensitization, relaxation techniques, and lorazepam for the secondary prevention of anticipatory CINV. No recommendation for the treatment of anticipatory CINV can be made.